A Phase I, Open-Label, Sequential, Single-Dose Clinical Trial to Evaluate the Pharmacokinetic, Pharmacodynamic, and Safety of IVL3001, a Finasteride-Based Novel Long-Acting Injection for Androgenetic Alopecia.
Heesun KimChoongho RyuMase LeeKyeong-Ryoon LeeJu Hee KimPublished in: Advances in therapy (2024)
ClinicalTrials.gov identifier, NCT04945226.